Immune checkpoint blockade (ICB) has transformed the treatment landscape of multiple malignancies, producing durable responses and long-term survival in subsets of patients with advanced cancer. However, the clinical benefit of ICB remains largely restricted to tumors displaying pre-existing immune activation, high tum...
P. Assumpção, A. Leal, W. Barra et al.· Frontiers in Immunology· 0 citations
ABSTRACT Background: Neoadjuvant chemotherapy is recommended as the standard of care for eligible patients with locally advanced resectable gastric adenocarcinoma. However, given the often-late diagnosis of this tumor, understanding post-neoadjuvant therapy lymph node involvement remains a determining factor in the pro...
G. Ishak, Luciana Roberta Do Vale Corrêa, Thaygo de Azevedo Neves et al.· Arquivos Brasileiros de Ciru...· 0 citations
Abstract Gastric adenocarcinoma (GAC) is characterized by molecular heterogeneity that limits early detection and targeted treatment. We applied weighted gene coexpression network analysis (WGCNA) to paired RNA-seq data from 119 GAC and peritumoral tissue (PTT) samples and identified six coexpression modules with disti...
Ronald Matheus da Silva Mourão, Fabiano Cordeiro Moreira, J. M. Costa da Silva et al.· Genetics and Molecular Biolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.